887593-51-3

Basic information

• Product Name: INDAN-5-YL-HYDRAZINE
• Synonyms: INDAN-5-YL-HYDRAZINE;CHEMBRDG-BB 4011144;2,3-dihydro-1H-inden-5-ylhydrazine(SALTDATA: HCl)
• CAS NO: 887593-51-3
• Molecular Formula: C₉H₁₂N₂
• Molecular Weight: 148.2
• Mol File: 887593-51-3.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 286°C at 760 mmHg
• Flash Point: 147.1°C
• Appearance: /
• Density: 1.184g/cm³
• Vapor Pressure: 0.00271mmHg at 25°C
• Refractive Index: 1.673
• CAS DataBase Reference: INDAN-5-YL-HYDRAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: INDAN-5-YL-HYDRAZINE(887593-51-3)
• EPA Substance Registry System: INDAN-5-YL-HYDRAZINE(887593-51-3)

Safety Data

• Hazardous Substances Data: 887593-51-3(Hazardous Substances Data)

Usage

InChI:InChI=1/C9H12N2/c10-11-9-5-4-7-2-1-3-8(7)6-9/h4-6,11H,1-3,10H2

Upstream product

• 24425-40-9 indan-5-amine 

Downstream Products

• 1257792-56-5 (Z)-4-{2-hydroxy-3-[N'-(1-indan-5-yl-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene)hydrazino]phenyl}thiophene-2-carboxylic acid 
• 1257792-52-1 (Z)-5-{2-hydroxy-3-[N'-(1-indan-5-yl-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene)hydrazino]phenyl}furan-2-carboxylic acid 
• 1176777-42-6 (Z)-2'-hydroxy-3'-[N'-(1-indan-5-yl-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene)hydrazino]biphenyl-3-carboxylic acid 

Relevant articles and documents

Double-ring substituted pyrazolone azo derivatives, their preparation and use (by machine translation)

The invention belongs to the field of pharmaceutical chemicals, relates to a twin-ring substituted pyrazolone azo derivatives, preparation method thereof, its pharmaceutical composition and use thereof. In particular, the present invention is shown in formula I compound or its pharmaceutically acceptable salt or solvate. The invention relates also to the preparation method of the compound I, which comprises a pharmaceutical composition and their pharmaceutical use. The invention of the formula I compounds are effective TPO agonist, is good medicine for treating thrombocytopenia. Type I. (by machine translation)

SPIROINDOLINE ANTIPARASITIC DERIVATIVES

The invention describes novel spiropiperidines of Formula (1A), (1B), and (1C) stereoisomers thereof, veterinarily acceptable salts thereof, compositions thereof, processes for making, and their use in animals as an antiparasitic. The variables A, R1, R2, R3, R4, v, m, 5, and n are as described herein.

BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF

The bicyclo-substituted pyrazolon-azo derivatives of formula (I) or pharmaceutical acceptable salts, hydrates or solvates thereof, methods for their preparation, pharmaceutical compositions containing the same and their use as a therapeutic agent, especially as thrombopoietin (TPO) mimetics and their use as agonists of thrombopoietin receptor are disclosed. The definition of substituents in formula (I) are the same as defined in the description.